Cargando…

Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative study

BACKGROUND AND PURPOSE: The use of a tissue expander (hydrogel) for sparing of the rectum from increased irradiation during prostate radiotherapy is becoming popular. The goal of this study is to investigate the effect of a tissue expander (hydrogel) on the intrafraction prostate motion during radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Juneja, Prabhjot, Kneebone, Andrew, Booth, Jeremy T., Thwaites, David I., Kaur, Ramandeep, Colvill, Emma, Ng, Jin A., Keall, Paul J., Eade, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619294/
https://www.ncbi.nlm.nih.gov/pubmed/26499473
http://dx.doi.org/10.1186/s13014-015-0526-1
Descripción
Sumario:BACKGROUND AND PURPOSE: The use of a tissue expander (hydrogel) for sparing of the rectum from increased irradiation during prostate radiotherapy is becoming popular. The goal of this study is to investigate the effect of a tissue expander (hydrogel) on the intrafraction prostate motion during radiotherapy. METHODS AND MATERIAL: Real time prostate motion was analysed for 26 patients and 742 fractions; 12 patients with and 14 patients without hydrogel (SpaceOAR™). The intra-fraction motion was quantified and compared between the two groups. RESULTS: The average (±standard deviation) of the mean motion during the treatment for patients with and without hydrogel was 1.5 (±0.8 mm) and 1.1 (±0.9 mm) respectively (p < 0.05). The average time of motion >3 mm for patients with and without hydrogel was 7.7 % (±1.1 %) and 4.5 % (±0.9 %) respectively (p > 0.05). The hydrogel age, fraction number and treatment time were found to have no effect (R(2) < 0.05) on the prostate motion. CONCLUSIONS: Differences in intrafraction motion in patients with hydrogel and without hydrogel were within measurement uncertainty (<1 mm). This result confirms that the addition of a spacer does not negate the need for intrafraction motion management if clinically indicated.